1
|
Elrefaey S, Massaro MA, Chiocca S, Chiesa
F and Ansarin M: HPV in oropharyngeal cancer: The basics to know in
clinical practice. Acta Otorhinolaryngol Ital. 34:299–309.
2014.PubMed/NCBI
|
2
|
Ausweger C, Burgschwaiger E, Kugler A,
Schmidbauer R, Steinek I, Todorov Y, Thurnher D and Krapfenbauer K:
Economic concerns about global healthcare in lung, head and neck
cancer: Meeting the economic challenge of predictive, preventive
and personalized medicine. EPMA J. 1:627–631. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gale N, Michaels L, Luzar B, Poljak M,
Zidar N, Fischinger J and Cardesa A: Current review on squamous
intraepithelial lesions of the larynx. Histopathology. 54:639–656.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: A systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
van Monsjou HS, Balm AJ, van den Brekel MM
and Wreesmann VB: Oropharyngeal squamous cell carcinoma: A unique
disease on the rise? Oral Oncol. 46:780–785. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mignogna MD, Fedele S and Russo Lo L: The
World Cancer Report and the burden of oral cancer. Eur J Cancer
Prev. 13:139–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sedrak M and Rizzolo D: Understanding the
link between HPV and oropharyngeal cancers. JAAPA. 22:42–46.
2009.PubMed/NCBI
|
8
|
Gillison ML: Human
papillomavirus-associated head and neck cancer is a distinct
epidemiologic, clinical, and molecular entity. Semin Oncol.
31:744–754. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Adelstein DJ and Rodriguez CP: Human
papillomavirus: Changing paradigms in oropharyngeal cancer. Curr
Oncol Rep. 12:115–120. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Guo M, Gong Y, Deavers M, Silva EG, Jan
YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, et al: Evaluation
of a commercialized in situ hybridization assay for detecting human
papillomavirus DNA in tissue specimens from patients with cervical
intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol.
46:274–280. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pannone G, Rodolico V, Santoro A, Muzio Lo
L, Franco R, Botti G, Aquino G, Pedicillo MC, Cagiano S, Campisi G,
et al: Evaluation of a combined triple method to detect causative
HPV in oral and oropharyngeal squamous cell carcinomas: p16
immunohistochemistry, consensus PCR HPV-DNA, and in situ
hybridization. Infect Agent Cancer. 7:42012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Stein AP, Saha S, Kraninger JL, Swick AD,
Yu M, Lambert PF and Kimple RJ: Prevalence of human papillomavirus
in oropharyngeal cancer: A systematic review. Cancer J. 21:138–146.
2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Williams GH and Stoeber K: Cell cycle
markers in clinical oncology. Curr Opin Cell Biol. 19:672–679.
2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Lee Y and Lim HS: Skp2 inhibitors: Novel
anticancer strategies. Curr Med Chem. 23:2363–2379. 2016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Qiu L, Lv J, Chen Y, Wang J and Wu R:
Expression of Skp2 and p27kip1 proteins in
hypopharyngeal squamous cell carcinoma and its clinical
significance. Oncol Lett. 10:3756–3760. 2015.PubMed/NCBI
|
20
|
Sugai T, Tsukahara M, Endoh M, Shioi Y,
Takebe N, Mue Y, Matsushita H, Toyota M and Suzuki K: Analysis of
cell cycle-related proteins in gastric intramucosal
differentiated-type cancers based on mucin phenotypes: A novel
hypothesis of early gastric carcinogenesis based on mucin
phenotype. BMC Gastroenterol. 10:552010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Ko E, Kim Y, Park SE, Cho EY, Han J, Shim
YM, Park J and Kim DH: Reduced expression of cyclin D2 is
associated with poor recurrence-free survival independent of cyclin
D1 in stage III non-small cell lung cancer. Lung Cancer.
77:401–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bahnassy AA, Zekri AR, El-Houssini S,
El-Shehaby AM, Mahmoud MR, Abdallah S and El-Serafi M: Cyclin A and
cyclin D1 as significant prognostic markers in colorectal cancer
patients. BMC Gastroenterol. 4:222004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Boscolo-Rizzo P, Pawlita M and Holzinger
D: From HPV-positive towards HPV-driven oropharyngeal squamous cell
carcinomas. Cancer Treat Rev. 42:24–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Miller DM, Thomas SD, Islam A, Muench D
and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res.
18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Inwald EC, Klinkhammer-Schalke M,
Hofstädter F, Zeman F, Koller M, Gerstenhauer M and Ortmann O:
Ki-67 is a prognostic parameter in breast cancer patients: Results
of a large population-based cohort of a cancer registry. Breast
Cancer Res Treat. 139:539–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(Review). Mol Med Rep. 11:1566–1572. 2015.PubMed/NCBI
|
28
|
Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH
and Lin MC: The biomarkers of human papillomavirus infection in
tonsillar squamous cell carcinoma-molecular basis and predicting
favorable outcome. Mod Pathol. 21:376–386. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Izumo T, Kirita T, Ariji E, Ozeki S, Okada
N, Okabe S, Okazaki Y, Omura K, Kusama M, Sato T, et al: Working
Group 1 on the ‘Guidelines for Clinical and Pathological Studies of
Oral Cancer’, Scientific Committee, Japan Society for Oral Tumors:
General rules for clinical and pathological studies on oral cancer:
A synopsis. Jpn J Clin Oncol. 42:1099–1109. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Cui M, Chan N, Liu M, Thai K, Malaczynska
J, Singh I, Zhang D and Ye F: Clinical performance of Roche Cobas
4800 HPV Test. J Clin Microbiol. 52:2210–2211. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gage JC, Sadorra M, Lamere BJ, Kail R,
Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M and Castle
PE: PaP Cohort Study Group: Comparison of the cobas Human
Papillomavirus (HPV) test with the hybrid capture 2 and linear
array HPV DNA tests. J Clin Microbiol. 50:61–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Stein AP, Saha S, Yu M, Kimple RJ and
Lambert PF: Prevalence of human papillomavirus in oropharyngeal
squamous cell carcinoma in the United States across time. Chem Res
Toxicol. 27:462–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Schache AG, Liloglou T, Risk JM, Filia A,
Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A,
Robinson M, et al: Evaluation of human papilloma virus diagnostic
testing in oropharyngeal squamous cell carcinoma: Sensitivity,
specificity, and prognostic discrimination. Clin Cancer Res.
17:6262–6271. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lin RJ, Lubpairee T, Liu KY, Anderson DW,
Durham S and Poh CF: Cyclin D1 overexpression is associated with
poor prognosis in oropharyngeal cancer. J Otolaryngol Head Neck
Surg. 42:232013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Liu J, Zhang M, Rose B, Veillard AS, Jones
D, Zhang X, Lee Soon C, Milross C and Hong A: Ki67 expression has
prognostic significance in relation to human papillomavirus status
in oropharyngeal squamous cell carcinoma. Ann Surg Oncol.
22:1893–1900. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Lai S, Wenaas AE, Sandulache VC, Hartman
C, Chiao E, Kramer J and Zevallos JP: Prognostic significance of
p16 cellular localization in oropharyngeal squamous cell carcinoma.
Ann Clin Lab Sci. 46:132–139. 2016.PubMed/NCBI
|
37
|
Saber CN, Larsen Grønhøj C, Dalianis T and
von Buchwald C: Immune cells and prognosis in HPV-associated
oropharyngeal squamous cell carcinomas: Review of the literature.
Oral Oncol. 58:8–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Yim EK and Park JS: The role of HPV E6 and
E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer
Res Treat. 37:319–324. 2005. View Article : Google Scholar : PubMed/NCBI
|
39
|
Fischer CA, Zlobec I, Green E, Probst S,
Storck C, Lugli A, Tornillo L, Wolfensberger M and Terracciano LM:
Is the improved prognosis of p16 positive oropharyngeal squamous
cell carcinoma dependent of the treatment modality? Int J Cancer.
126:1256–1262. 2010.PubMed/NCBI
|
40
|
Friedman JM, Stavas MJ and Cmelak AJ:
Clinical and scientific impact of human papillomavirus on head and
neck cancer. World J Clin Oncol. 5:781–791. 2014. View Article : Google Scholar : PubMed/NCBI
|
41
|
Sugai T, Nakamura SI, Habano W, Uesugi N,
Sato H, Yoshida T and Orii S: Usefulness of proliferative activity,
DNA ploidy pattern and p53 products as diagnostic adjuncts in
colorectal adenomas and intramucosal carcinomas. Pathol Int.
49:617–625. 1999. View Article : Google Scholar : PubMed/NCBI
|
42
|
Lassaletta L, Brandáriz JA, Benito A, de
la Cruz J, Gómez C, Ballestín C, Hitt R, Colomer R and
Alvarez-Vicent JJ: p53 expression in locally advanced pharyngeal
squamous cell carcinoma. Arch Otolaryngol Head Neck Surg.
125:1356–1359. 1999. View Article : Google Scholar : PubMed/NCBI
|
43
|
Shinohara S, Kikuchi M, Tona R, Kanazawa
Y, Kishimoto I, Harada H, Imai Y and Usami Y: Prognostic impact of
p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Jpn J Clin Oncol. 44:232–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yang RM, Naitoh J, Murphy M, Wang HJ,
Phillipson J, deKernion JB, Loda M and Reiter RE: Low p27
expression predicts poor disease-free survival in patients with
prostate cancer. J Urol. 159:941–945. 1998. View Article : Google Scholar : PubMed/NCBI
|
45
|
Hayashi H, Ito T, Yazawa T, Ikeda M,
Inayama Y, Nakatani Y, Kameda Y, Nakamura N and Kitamura H: Reduced
expression of p27/Kip1 is associated with the development of
pulmonary adenocarcinoma. J Pathol. 192:26–31. 2000. View Article : Google Scholar : PubMed/NCBI
|
46
|
Yasui W, Kudo Y, Semba S, Yokozaki H and
Tahara E: Reduced expression of cyclin-dependent kinase inhibitor
p27Kip1 is associated with advanced stage and invasiveness of
gastric carcinomas. Jpn J Cancer Res. 88:625–629. 1997. View Article : Google Scholar : PubMed/NCBI
|
47
|
Mitomi H, Ohkura Y, Fukui N, Kanazawa H,
Kishimoto I, Nakamura T, Yokoyama K, Sada M, Kobayashi K, Tanabe S,
et al: P21WAF1/CIP1 expression in colorectal carcinomas is related
to Kras mutations and prognosis. Eur J Gastroenterol Hepatol.
19:883–889. 2007. View Article : Google Scholar : PubMed/NCBI
|
48
|
Huang X-P, Rong T-H, Lin P, Wu Q-L, Yao
G-Y, Hou J-H, Su X-D, Li X-D, Li B-J, Zhang P-Y, et al: Cyclin D1
overexpression in esophageal cancer from southern China and its
clinical significance. Cancer Lett. 231:94–101. 2006. View Article : Google Scholar : PubMed/NCBI
|
49
|
Li Y, Wei J, Xu C, Zhao Z and You T:
Prognostic significance of cyclin D1 expression in colorectal
cancer: A meta-analysis of observational studies. PLoS One.
9:e945082014. View Article : Google Scholar : PubMed/NCBI
|